{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:41:15Z","timestamp":1790066475669,"version":"4.0.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T00:00:00Z","timestamp":1520553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1093\/ckj\/sfy005","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T20:11:13Z","timestamp":1516133473000},"page":"36-41","source":"Crossref","is-referenced-by-count":38,"title":["Antiphospholipase 2 receptor antibody levels to predict complete spontaneous remission in primary membranous nephropathy"],"prefix":"10.1093","volume":"12","author":[{"given":"Lida M","family":"Rodas","sequence":"first","affiliation":[{"name":"Servicio de Nefrolog\u00eda y Trasplante Renal, Hospital Cl\u00ednic, Departamento de Medicina, Universidad de Barcelona, Institut d\u2019 Invesigacions biom\u00e8diques Agust Pi i Sunyer (IDIBAPS), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Matas-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Servicio de Nefrolog\u00eda y Trasplante Renal, Hospital Cl\u00ednic, Departamento de Medicina, Universidad de Barcelona, Institut d\u2019 Invesigacions biom\u00e8diques Agust Pi i Sunyer (IDIBAPS), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xoana","family":"Barros","sequence":"additional","affiliation":[{"name":"Servicio de Nefrolog\u00eda, Hospital Josep Trueta, Girona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Blasco","sequence":"additional","affiliation":[{"name":"Servicio de Nefrolog\u00eda y Trasplante Renal, Hospital Cl\u00ednic, Departamento de Medicina, Universidad de Barcelona, Institut d\u2019 Invesigacions biom\u00e8diques Agust Pi i Sunyer (IDIBAPS), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odette","family":"Vi\u00f1as","sequence":"additional","affiliation":[{"name":"Servicio de Inmunolog\u00eda, Centro de Diagn\u00f3stico Biom\u00e9dico (CDB), Hospital Cl\u00ednic, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Llobell","sequence":"additional","affiliation":[{"name":"Servicio de Inmunolog\u00eda, Centro de Diagn\u00f3stico Biom\u00e9dico (CDB), Hospital Cl\u00ednic, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Martin","sequence":"additional","affiliation":[{"name":"Servicio de Nefrolog\u00eda, Hospital Josep Trueta, Girona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F","family":"Quintana","sequence":"additional","affiliation":[{"name":"Servicio de Nefrolog\u00eda y Trasplante Renal, Hospital Cl\u00ednic, Departamento de Medicina, Universidad de Barcelona, Institut d\u2019 Invesigacions biom\u00e8diques Agust Pi i Sunyer (IDIBAPS), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.ajkd.2016.01.030","article-title":"Membranous nephropathy: a journey from bench to bedside","volume":"68","author":"Francis","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B2","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/TP.0000000000000630","article-title":"Antiphospholipase A2 receptor antibody levels predict the risk of post transplantation recurrence of membranous nephropathy","volume":"99","author":"Quintana","year":"2015","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B3","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.2012030242","article-title":"Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy","volume":"23","author":"Hofstra","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B4","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2215\/CJN.01330209","article-title":"The natural history of the non-nephrotic membranous nephropathy patient","volume":"4","author":"Hladunewich","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B5","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/S0140-6736(15)60731-0","article-title":"Pathophysiological advances in membranous nephropathy: time for a shift in patient\u2019s care","volume":"385","author":"Ronco","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B6","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ncpneph0915","article-title":"Remission of proteinuria in primary glomerulonephritis: we know the goal but do we know the price?","volume":"4","author":"Philibert","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B8","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/ki.1992.374","article-title":"Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis","volume":"42","author":"Pei","year":"1992","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.nefro.2015.05.026","article-title":"Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor","volume":"35","author":"Jatem Escalante","year":"2015","journal-title":"Nefrologia"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B10","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2215\/CJN.07210810","article-title":"Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy","volume":"6","author":"Hofstra","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1681\/ASN.2010090967","article-title":"Anti-phospholipase A2 receptor antibody in membranous nephropathy","volume":"22","author":"Qin","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B13","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1681\/ASN.2013040430","article-title":"Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy","volume":"25","author":"Hoxha","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B14","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ki.2012.486","article-title":"Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy","volume":"83","author":"Kanigicherla","year":"2013","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000437236","article-title":"Anti-PLA2R antibodies as a prognostic factor in PLA2R-related membranous nephropathy","volume":"42","author":"Timmermans","year":"2015","journal-title":"Am J Nephrol"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B16","doi-asserted-by":"crossref","first-page":"143274","DOI":"10.1155\/2014\/143274","article-title":"Antiphospholipase A2 receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy","volume":"2014","author":"Behnert","year":"2014","journal-title":"J Immunol Res"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B17","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1681\/ASN.2010111125","article-title":"Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy","volume":"22","author":"Beck","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ki.2010.34","article-title":"Membranous nephropathy: recent travels and new roads ahead","volume":"77","author":"Beck","year":"2010","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1681\/ASN.2009080861","article-title":"Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy","volume":"21","author":"Polanco","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/ckj\/sfw121","article-title":"Antiphospholipase A2 receptor antibody levels at diagnosis predicts spontaneousremission of idiopathic membranous nephropathy","volume":"10","author":"Jullien","year":"2017","journal-title":"Clin Kidney J"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1681\/ASN.2016070776","article-title":"A proposal for a serology-based approach to membranous nephropathy","volume":"28","author":"De Vriese","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019020706494223900_sfy005-B22","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2215\/CJN.11761116","article-title":"Primary membranous nephropathy","volume":"12","author":"Couser","year":"2017","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/12\/1\/36\/27721375\/sfy005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T12:12:47Z","timestamp":1549541567000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/12\/1\/36\/4925498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,9]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,3,9]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfy005","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,3,9]]}}}